ATE522816T1 - Endogenes morphin oder natürlich vorkommender metabolit davon als marker für sepsis - Google Patents

Endogenes morphin oder natürlich vorkommender metabolit davon als marker für sepsis

Info

Publication number
ATE522816T1
ATE522816T1 AT08863184T AT08863184T ATE522816T1 AT E522816 T1 ATE522816 T1 AT E522816T1 AT 08863184 T AT08863184 T AT 08863184T AT 08863184 T AT08863184 T AT 08863184T AT E522816 T1 ATE522816 T1 AT E522816T1
Authority
AT
Austria
Prior art keywords
naturally occurring
morphine
endogene
sepsis
marker
Prior art date
Application number
AT08863184T
Other languages
English (en)
Inventor
Yannick Goumon
Dominique Aunis
Marie-Helene Metz-Boutigue
Francis Schneider
Ingeborg Welters
Original Assignee
Inst Nat Sante Rech Med
Justus Liebig Uni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Justus Liebig Uni filed Critical Inst Nat Sante Rech Med
Application granted granted Critical
Publication of ATE522816T1 publication Critical patent/ATE522816T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT08863184T 2007-12-18 2008-12-18 Endogenes morphin oder natürlich vorkommender metabolit davon als marker für sepsis ATE522816T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07301692 2007-12-18
PCT/EP2008/067907 WO2009077593A1 (en) 2007-12-18 2008-12-18 Endogenous morphine or a naturally occuring metabolite thereof as a marker for infection

Publications (1)

Publication Number Publication Date
ATE522816T1 true ATE522816T1 (de) 2011-09-15

Family

ID=39298209

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08863184T ATE522816T1 (de) 2007-12-18 2008-12-18 Endogenes morphin oder natürlich vorkommender metabolit davon als marker für sepsis

Country Status (5)

Country Link
US (1) US20100304411A1 (de)
EP (1) EP2223122B1 (de)
AT (1) ATE522816T1 (de)
ES (1) ES2373009T3 (de)
WO (1) WO2009077593A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2717057A1 (de) 2012-10-04 2014-04-09 Cisbio Bioassays Morphin-6-glucuronid-Derivate, Immunogene und Immunassay
CN104101710B (zh) * 2014-04-02 2016-02-03 浙江省海洋开发研究院 一种海水鱼内生吗啡的检测方法及其检测试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500345A (en) * 1989-04-25 1996-03-19 Iatron Laboratories, Inc. Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein
US5272258A (en) * 1989-06-29 1993-12-21 Rush-Presbyterian-St. Luke's Medical Center Monoclonal antibodies to C-reactive protein
CA2170402C (en) * 1993-08-24 2000-07-18 Michael P. Allen Novel disposable electronic assay device
FI20022048A0 (fi) * 2002-11-18 2002-11-18 Valtion Teknillinen Ei-kompetetiivinen immunomääritys pienille analyyteille

Also Published As

Publication number Publication date
EP2223122B1 (de) 2011-08-31
US20100304411A1 (en) 2010-12-02
ES2373009T3 (es) 2012-01-30
EP2223122A1 (de) 2010-09-01
WO2009077593A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP2047268A4 (de) Indikatorsystem zur bestimmung einer analytenkonzentration
HK1124748A1 (en) System for in-vivo measurement of an analyte concentration
BRPI0915619A2 (pt) métodos para determinar uma probabilidade de que um sujeito tenha contribuído com material genético para amostra de teste de material genético, para caracterizar amostra de teste de material genético e para determinar se uma pessoa de interesse contribuiu com material genético para uma amostra de teste de material genético, kit para análise de amostra de teste de material genético e sistema para determinar se um sujeito contribuiu com material genético para uma amostra
EP2392921A4 (de) Verfahren zur messung der temperatur einer biologischen probe, verfahren zur messung der konzentration einer biologischen probe, sensorchip und biosensorensystem
SI1972275T1 (sl) Sistem za merjenje koncentracije analita in vivo
BR112014010696A2 (pt) método para identificar uma molécula de analito em uma amostra biológica, sensor para capturar um analito de interesse de uma amostra biológica, e, detector
IL225386A (en) A method for identifying cancer by identifying ereg protein
FI20075439A0 (fi) Automatisoitu instrumentointi ja menetelmä näytteiden mittaamiseksi
DE112009003237A5 (de) Biopsie-instrument zur anreicherung von probenmaterial
BRPI0811453A2 (pt) Sistema de análise de amostra
JP2010048806A5 (ja) 流体内検体濃度検知システム
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
EP2284526A4 (de) Biosensorsystem, sensorspitze und verfahren zur messung einer analytkonzentration in einer blutprobe
EP2405264A4 (de) Biosensorensystem und vorrichtung zum messen einer analytkonzentration
HK1142125A1 (en) System for measuring an analyte concentration in a bodily fluid sample
DE602007007775D1 (de) Reagenz für hämoglobinabbau
HK1165001A1 (zh) 利用免疫法測定生物樣品中的雌馬酚的方法、用於該測定的試劑盒、以及判定受試者的雌馬酚產生能力的方法
FI20075191A0 (fi) Väline ja menetelmä analyysiä varten
AT10236U3 (de) Messanordnung und verfahren zur erfassung von messdaten
BR112014031958A2 (pt) bag3 como marcador de tecido e soro bioquímico
IT1396810B1 (it) Dispositivo per la rilevazione di analiti in un campione biologico
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties